{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T07:28:52Z","timestamp":1780471732030,"version":"3.54.1"},"reference-count":27,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2015,10,1]],"date-time":"2015-10-01T00:00:00Z","timestamp":1443657600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmaceutical and Biomedical Analysis"],"published-print":{"date-parts":[[2015,10]]},"DOI":"10.1016\/j.jpba.2015.05.001","type":"journal-article","created":{"date-parts":[[2015,5,8]],"date-time":"2015-05-08T12:19:19Z","timestamp":1431087559000},"page":"8-11","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":25,"special_numbering":"C","title":["A LC\u2013MS method to quantify tenofovir urinary concentrations in treated patients"],"prefix":"10.1016","volume":"114","author":[{"given":"Marco","family":"Simiele","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiara","family":"Carcieri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amedeo","family":"De Nicol\u00f2","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandra","family":"Ariaudo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mauro","family":"Sciandra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Calcagno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefano","family":"Bonora","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni","family":"Di Perri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1321-4126","authenticated-orcid":false,"given":"Antonio","family":"D\u2019Avolio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jpba.2015.05.001_bib0140","unstructured":"WHO, HIV\/AIDS. Fact sheet N360, (2013)."},{"key":"10.1016\/j.jpba.2015.05.001_bib0145","unstructured":"WHO, Hepatitis B. Fact sheet N204, (2013)."},{"issue":"Suppl 1","key":"10.1016\/j.jpba.2015.05.001_bib0150","doi-asserted-by":"crossref","first-page":"i47","DOI":"10.1136\/gutjnl-2012-302062","article-title":"HIV and viral hepatitis coinfections: Advances and challenges","volume":"61","author":"Lacombe","year":"2012","journal-title":"Gut"},{"key":"10.1016\/j.jpba.2015.05.001_bib0155","doi-asserted-by":"crossref","first-page":"e68152","DOI":"10.1371\/journal.pone.0068152","article-title":"Suppression of HBV by tenofovir in HBV\/HIV coinfected patients: A systematic review and meta-analysis","volume":"8","author":"Price","year":"2013","journal-title":"PLoS ONE"},{"key":"10.1016\/j.jpba.2015.05.001_bib0160","doi-asserted-by":"crossref","first-page":"17360","DOI":"10.3748\/wjg.v20.i46.17360","article-title":"Hepatitis B and human immunodeficiency virus co-infection","volume":"20","author":"Phung","year":"2014","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.jpba.2015.05.001_bib0165","unstructured":"G. Sciences, FDA Advisory Committee Briefing Document_Viread, NDA 21_356, (2001)."},{"key":"10.1016\/j.jpba.2015.05.001_bib0170","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1128\/AAC.42.3.612","article-title":"Anti-human immunodeficiency virus activity and cellular metabolism of a potential prodrug of the acyclic nucleoside phosphonate 9-R-(2-phosphonomethoxypropyl)adenine (PMPA), bis(isopropyloxymethylcarbonyl)PMPA","volume":"42","author":"Robbins","year":"1998","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.jpba.2015.05.001_bib0175","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1016\/j.jmb.2008.10.071","article-title":"Structure and function of HIV-1 reverse transcriptase: molecular mechanisms of polymerization and inhibition","volume":"385","author":"Sarafianos","year":"2009","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.jpba.2015.05.001_bib0180","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1111\/j.1468-1293.2009.00716.x","article-title":"Tenofovir-associated renal and bone toxicity","volume":"10","author":"Woodward","year":"2009","journal-title":"HIV Med."},{"key":"10.1016\/j.jpba.2015.05.001_bib0185","unstructured":"FDA, Highlights of prescribing information_Viread, (2013)."},{"key":"10.1016\/j.jpba.2015.05.001_bib0190","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1517\/14740331003627458","article-title":"Renal toxicity associated with tenofovir use","volume":"9","author":"Rodriguez-Novoa","year":"2010","journal-title":"Expert Opin. Drug Saf."},{"key":"10.1016\/j.jpba.2015.05.001_bib0195","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1053\/j.ajkd.2011.01.022","article-title":"Tenofovir-associated kidney toxicity in HIV-infected patients: a review of the evidence","volume":"57","author":"Hall","year":"2011","journal-title":"Am. J. Kidney Dis."},{"key":"10.1016\/j.jpba.2015.05.001_bib0200","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1681\/ASN.2012080857","article-title":"Tenofovir effect on the kidneys of HIV-infected patients: a double-edged sword?","volume":"24","author":"Tourret","year":"2013","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.jpba.2015.05.001_bib0205","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1097\/QAD.0b013e3283262a64","article-title":"Kidney tubular abnormalities in the absence of impaired glomerular function in HIV patients treated with tenofovir","volume":"23","author":"Labarga","year":"2009","journal-title":"AIDS"},{"key":"10.1016\/j.jpba.2015.05.001_bib0210","doi-asserted-by":"crossref","first-page":"1840","DOI":"10.1128\/AAC.02434-12","article-title":"Tenofovir plasma concentrations according to companion drugs: A cross-sectional study of HIV-positive patients with normal renal function","volume":"57","author":"Calcagno","year":"2013","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.jpba.2015.05.001_bib0215","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1097\/QAD.0b013e32833202e2","article-title":"Impairment in kidney tubular function in patients receiving tenofovir is associated with higher tenofovir plasma concentrations","volume":"24","author":"Rodriguez-Novoa","year":"2010","journal-title":"AIDS"},{"key":"10.1016\/j.jpba.2015.05.001_bib0220","first-page":"53","article-title":"Can urine lamivudine be used to monitor antiretroviral treatment adherence?","volume":"8","author":"Kumar","year":"2006","journal-title":"MedGenMed"},{"key":"10.1016\/j.jpba.2015.05.001_bib0225","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.jchromb.2007.04.015","article-title":"Relevance of a combined UV and single mass spectrometry detection for the determination of tenofovir in human plasma by HPLC in therapeutic drug monitoring","volume":"854","author":"El Barkil","year":"2007","journal-title":"J. Chromatogr. B Analyt. Technol. Biomed. Life Sci."},{"key":"10.1016\/j.jpba.2015.05.001_bib0230","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/S1570-0232(02)00933-9","article-title":"Determination of tenofovir in human plasma by high-performance liquid chromatography with spectrofluorimetric detection","volume":"785","author":"Jullien","year":"2003","journal-title":"J. Chromatogr. B Analyt. Technol. Biomed. Life Sci."},{"key":"10.1016\/j.jpba.2015.05.001_bib0235","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.jchromb.2005.06.019","article-title":"Simultaneous quantification of emtricitabine and tenofovir in human plasma using high-performance liquid chromatography after solid phase extraction","volume":"822","author":"Rezk","year":"2005","journal-title":"J. Chromatogr. B Analyt. Technol. Biomed. Life Sci."},{"key":"10.1016\/j.jpba.2015.05.001_bib0240","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/S1570-0232(03)00225-3","article-title":"Liquid chromatographic assay for the antiviral nucleotide analogue tenofovir in plasma using derivatization with chloroacetaldehyde","volume":"791","author":"Sparidans","year":"2003","journal-title":"J. Chromatogr. B Analyt. Technol. Biomed. Life Sci."},{"key":"10.1016\/j.jpba.2015.05.001_bib0245","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/j.clinbiochem.2004.11.007","article-title":"Matrix effects: The Achilles heel of quantitative high-performance liquid chromatography\u2013electrospray-tandem mass spectrometry","volume":"38","author":"Taylor","year":"2005","journal-title":"Clin. Biochem."},{"key":"10.1016\/j.jpba.2015.05.001_bib0250","unstructured":"FDA, Guidance for Industry Bioanalytical Method Validation, (2013)."},{"key":"10.1016\/j.jpba.2015.05.001_bib0255","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1093\/chromsci\/46.6.524","article-title":"A new assay based on solid-phase extraction procedure with LC\u2013MS to measure plasmatic concentrations of tenofovir and emtricitabine in HIV infected patients","volume":"46","author":"D\u2019Avolio","year":"2008","journal-title":"J. Chromatogr. Sci."},{"key":"10.1016\/j.jpba.2015.05.001_bib0260","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/S1570-0232(03)00333-7","article-title":"Sensitive determination of tenofovir in human plasma samples using reversed-phase liquid chromatography","volume":"793","author":"Sentenac","year":"2003","journal-title":"J. Chromatogr. B Analyt. Technol. Biomed. Life Sci."},{"key":"10.1016\/j.jpba.2015.05.001_bib0265","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.jchromb.2005.10.015","article-title":"Sensitive assay for determining plasma tenofovir concentrations by LC\/MS\/MS","volume":"830","author":"Delahunty","year":"2006","journal-title":"J. Chromatogr. B Analyt. Technol. Biomed. Life Sci."},{"key":"10.1016\/j.jpba.2015.05.001_bib0270","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1097\/QAI.0b013e3182965d45","article-title":"Antiviral activity, safety, and pharmacokinetics\/pharmacodynamics of tenofovir alafenamide as 10-day monotherapy in HIV-1-positive adults","volume":"63","author":"Ruane","year":"2013","journal-title":"J. Acquir. Immune Defic. Syndr."}],"container-title":["Journal of Pharmaceutical and Biomedical Analysis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0731708515002782?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0731708515002782?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,24]],"date-time":"2019-08-24T15:55:18Z","timestamp":1566662118000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0731708515002782"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,10]]},"references-count":27,"alternative-id":["S0731708515002782"],"URL":"https:\/\/doi.org\/10.1016\/j.jpba.2015.05.001","relation":{},"ISSN":["0731-7085"],"issn-type":[{"value":"0731-7085","type":"print"}],"subject":[],"published":{"date-parts":[[2015,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A LC\u2013MS method to quantify tenofovir urinary concentrations in treated patients","name":"articletitle","label":"Article Title"},{"value":"Journal of Pharmaceutical and Biomedical Analysis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpba.2015.05.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}